TargetMol

LY2510924 acetate(1088715-84-7 free base)

Product Code:
 
TAR-T15805L
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T15805L-1mg1mg£201.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15805L-5mg5mg£330.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15805L-10mg10mg£458.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15805L-1mL1 mL * 10 mM (in DMSO)£687.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15805L-25mg25mg£704.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15805L-50mg50mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15805L-100mg100mg£1,267.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ly2510924 acetate is an potent and selective CXCR4 antagonist. It prevents the binding of SDF-1 to CXCR4 with an IC50 of 0.079 nM.
CAS:
T15805L
Formula:
C64H91N13O13
Molecular Weight:
1250.49
Pathway:
Autophagy; GPCR/G Protein; Immunology/Inflammation
Purity:
0.9732
SMILES:
O=C(C(NC(C(NC(C(CCCCNC(C)C)N1)=O)CCCNC(N)=O)=O)CC2=CC=C3C=CC=CC3=C2)NCC(N[C@H](CCC(N[C@H](C(N[C@H](C1=O)CC4=CC=C(C=C4)O)=O)CC5=CC=CC=C5)=O)C(N[C@H](C(N)=O)CCCCNC(C)C)=O)=O.CC(O)=O
Target:
CXCR

References

1. Peng S B , Zhang X , Paul D , et al. Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models[J]. Molecular Cancer Therapeutics, 2015, 14(2):480.